Randomized Clinical Trial
Copyright ©The Author(s) 2023.
World J Diabetes. Dec 15, 2023; 14(12): 1813-1823
Published online Dec 15, 2023. doi: 10.4239/wjd.v14.i12.1813
Table 1 Baseline characteristics, n (%)
CharacteristicsAcupuncture group (n = 31)Control group (n = 31)
Age mean (SD)66.7 (7.6)69.5 (7.2)
Age group > 60 yr24 (77.4)27 (87.1)
Male25 (80.6)24 (77.4)
BMI > 25 kg/m²27 (87.1)27 (87.1)
Duration of neuropathy symptoms > 5 yr14 (45.2)19 (61.3)
Types of neuropathy
Painful neuropathy4 (12.9)7 (22.6)
Mixed neuropathy27 (87.1)24 (77.4)
Severe neuropathy3 (10.0)7 (24.1)
Palpable pedal pulse right29 (93.6)25 (80.7)
Palpable pedal pulse left25 (83.3)26 (86.7)
Relevant comorbidities (cardiovascular, hyperlipidemia, arthrosis)27 (87.1)27 (87.1)
Previous treatment with medication 12 (38.1)13 (41.9)
NPSI total intensity score
    Mean (SD)28.1 ± 15.828.8 ± 20.5
    Median (range)30 (4-63)23 (0-72)
11-NRS scale for numbness
    Mean (SD)5.8 ± 1.85.8 ± 2.0
    Median (range)6 (0-9)6 (1-8)
NDS
    Mean (SD)8.1 ± 2.68.1 ± 1.9
    Median (range)9 (2-10)8 (4-10)
NSS
    Mean (SD)7.2 ± 1.87.6 ± 1.5
    Median (range)7 (4-10)7 (5-10)
TNSc Total
    Mean (SD)10.2 ± 4.111.3 ± 3.9
    Median (range)11 (2-17)11 (6-19)
NSS Sub-groups
    Mild3 (9.7)0 (0.0)
    Moderate8 (25.8)6 (19.3)
    Severe20 (64.5)25 (80.7)
Sural nerve conduct velocity of both legs (m/s)
    Mean (SD)40.9 ± 13.633.6 ± 19.9
    Median (range)44 (0-59)44 (0-55)
Sural nerve Amplitude of the sensory nerve action potential of both legs (µV)
    Mean (SD)4.0 ± 1.93.7 ± 2.1
    Median (range)4 (0-7)4 (0-7)